Oppenheimer & Co’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-30,222
| Closed | -$855K | – | 1583 |
|
2024
Q3 | $855K | Buy |
+30,222
| New | +$855K | 0.01% | 848 |
|
2024
Q2 | – | Sell |
-13,995
| Closed | -$459K | – | 1458 |
|
2024
Q1 | $459K | Buy |
+13,995
| New | +$459K | 0.01% | 1023 |
|
2023
Q2 | – | Sell |
-6,360
| Closed | -$206K | – | 1431 |
|
2023
Q1 | $206K | Buy |
+6,360
| New | +$206K | ﹤0.01% | 1256 |
|
2022
Q4 | – | Sell |
-6,454
| Closed | -$232K | – | 1378 |
|
2022
Q3 | $232K | Buy |
+6,454
| New | +$232K | 0.01% | 1161 |
|
2022
Q2 | – | Sell |
-6,360
| Closed | -$206K | – | 1452 |
|
2022
Q1 | $206K | Buy |
+6,360
| New | +$206K | ﹤0.01% | 1340 |
|
2021
Q2 | – | Sell |
-31,000
| Closed | -$626K | – | 1526 |
|
2021
Q1 | $626K | Hold |
31,000
| – | – | 0.01% | 874 |
|
2020
Q4 | $497K | Hold |
31,000
| – | – | 0.01% | 886 |
|
2020
Q3 | $385K | Hold |
31,000
| – | – | 0.01% | 895 |
|
2020
Q2 | $221K | Sell |
31,000
-18,060
| -37% | -$129K | 0.01% | 1077 |
|
2020
Q1 | $266K | Buy |
49,060
+5,000
| +11% | +$27.1K | 0.01% | 939 |
|
2019
Q4 | $399K | Sell |
44,060
-48,414
| -52% | -$438K | 0.01% | 926 |
|
2019
Q3 | $665K | Buy |
92,474
+2,847
| +3% | +$20.5K | 0.02% | 704 |
|
2019
Q2 | $712K | Buy |
89,627
+5,324
| +6% | +$42.3K | 0.02% | 694 |
|
2019
Q1 | $1.06M | Sell |
84,303
-15,585
| -16% | -$196K | 0.03% | 571 |
|
2018
Q4 | $1.99M | Buy |
99,888
+40,395
| +68% | +$806K | 0.06% | 338 |
|
2018
Q3 | $1.69M | Buy |
59,493
+3,456
| +6% | +$98.1K | 0.04% | 446 |
|
2018
Q2 | $1.18M | Buy |
56,037
+9,091
| +19% | +$191K | 0.03% | 533 |
|
2018
Q1 | $669K | Buy |
+46,946
| New | +$669K | 0.02% | 747 |
|